Cortexyme, Inc. Contracts & Agreements

60 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Quince Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Quince Therapeutics, Inc. Warrant to Purchase Common Stock or Pre-Funded Warrants (2025)
Warrant Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Securities Purchase Agreement between Quince Therapeutics, Inc. and Investors (June 12, 2025)
Purchase Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Quince Therapeutics, Inc. Registration Rights Agreement with Investors (June 12, 2025)
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2025
Description of Quince Therapeutics, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
2025
Quince Therapeutics, Inc. Amended and Restated Outside Director Compensation Policy (Effective December 2, 2024)
Compensation Agreements
Cortexyme, Inc.
Biotechnology
2025
Quince Therapeutics, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Cortexyme, Inc.
Biotechnology
DE
2024
Accession, Amendment and Restatement Agreement to Finance Contract between European Investment Bank and Erydel S.p.A. (with Guarantors)
Investment Agreements
Cortexyme, Inc.
Biotechnology
CA
2024
Autonomous First Demand Guarantee Agreement between Quince Therapeutics, Inc. and European Investment Bank
Guaranty Agreements
Cortexyme, Inc.
Biotechnology
DE
2024
Transition and Separation Agreement between Quince Therapeutics, Inc., Novosteo, Inc., and Karen Smith (July 21, 2023)
Separation Agreements
Cortexyme, Inc.
Biotechnology
2023
Quince Therapeutics, Inc. Employment Agreement with Charles Ryan (President)
Employment Agreements
Cortexyme, Inc.
Biotechnology
NJ
2023
Quince Therapeutics, Inc. Executive Change in Control and Severance Agreement with Charles Ryan
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2023
Amendment No. 3 to License Agreement between Purdue Research Foundation and Quince Therapeutics, Inc.
License Agreements
Cortexyme, Inc.
Biotechnology
2023
Stock Purchase Agreement among Quince Therapeutics, Inc., EryDel Italy, Inc., EryDel S.p.A., Shareholders, and Shareholder Representative Services LLC
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Asset Purchase Agreement between Quince Therapeutics, Inc. and Lighthouse Pharmaceuticals, Inc. dated January 27, 2023
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Rights Agreement between Quince Therapeutics, Inc. and American Stock Transfer & Trust Company, LLC (April 5, 2023)
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Amendment No. 2 to License Agreement between Purdue Research Foundation and Novosteo, Inc.
License Agreements
Cortexyme, Inc.
Biotechnology
2022
Separation Agreement between Cortexyme, Inc. and Michael Detke dated May 2, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
DE
2022
Employment Offer Letter between Novosteo Inc. and Brendan Hannah (Cortexyme Acquisition)
Employment Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Employment Offer Letter between Novosteo Inc. and Karen Smith (May 2022)
Employment Agreements
Cortexyme, Inc.
Biotechnology
CO
2022
Employment Offer Letter Agreement between Novosteo Inc. and Dirk Thye, MD (May 2022)
Employment Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Cortexyme, Inc. Transition Separation Agreement with Caryn G. McDowell dated May 19, 2022
Transition Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Brendan Hannah
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Karen Smith (May 2022)
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CO
2022
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Dirk Thye, MD
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Cortexyme, Inc. Separation Agreement with Christopher Lowe (June 10, 2022)
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Sublease Agreement between ICON Clinical Research, LLC and Cortexyme, Inc. dated May 5, 2022
Lease Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Consent to Sublease Agreement among 601 & 651 Gateway Center LP, ICON Clinical Research, LLC, and Cortexyme, Inc. dated June 8, 2022
Lease Agreements
Cortexyme, Inc.
Biotechnology
2022
Separation and Severance Agreement between Cortexyme, Inc. and Leslie Holsinger dated July 15, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Cortexyme, Inc. Outside Director Compensation Policy (Amended and Restated June 7, 2022)
Compensation Agreements
Cortexyme, Inc.
Biotechnology
2022
License Agreement between Purdue Research Foundation and Novosteo Inc. (June 3, 2020)
License Agreements
Cortexyme, Inc.
Biotechnology
IN
2022
Amendment No. 1 to License Agreement between Purdue Research Foundation and Novosteo Inc.
License Agreements
Cortexyme, Inc.
Biotechnology
2022
Agreement and Plan of Merger and Reorganization among Cortexyme, Inc., Quince Merger Subs, Novosteo Inc., and Fortis Advisors LLC (May 9, 2022)
Merger Agreements
Cortexyme, Inc.
Biotechnology
DE
2022
Separation Agreement between Cortexyme, Inc. and Casey C. Lynch dated February 1, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Separation Agreement between Cortexyme, Inc. and Stephen S. Dominy, M.D. dated February 1, 2022
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2022
Open Market Sale Agreement between Cortexyme, Inc. and Jefferies LLC (December 23, 2021)
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
NY
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Ted Monohon
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Casey C. Lynch
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Caryn McDowell
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Christopher Lowe (May 18, 2020)
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Leslie Holsinger, Ph.D.
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Michael Detke
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Cortexyme, Inc. Executive Change in Control and Severance Agreement with Stephen S. Dominy, M.D.
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2021
Third Amendment to Sub-Sublease between Verily Life Sciences LLC and Cortexyme, Inc. (July 15, 2021)
Lease Agreements
Cortexyme, Inc.
Biotechnology
2021
Description of Cortexyme, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2021
Second Amendment to Sub-Sublease Agreement between Verily Life Sciences LLC and Cortexyme, Inc.
Lease Agreements
Cortexyme, Inc.
Biotechnology
2020
Separation and Release Agreement between Cortexyme, Inc. and Kristen Gafric dated April 27, 2020
Separation Agreements
Cortexyme, Inc.
Biotechnology
CA
2020
Cortexyme, Inc. Executive Change in Control and Severance Agreement
Change of Control Agreements
Cortexyme, Inc.
Biotechnology
CA
2020
Description of Cortexyme, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2020
Stock Purchase Agreement between Cortexyme, Inc. and Purchaser (February 5, 2020)
Stock Agreements
Cortexyme, Inc.
Biotechnology
2020
Amendment No. 1 to Sub-Sublease Agreement between Verily Life Sciences LLC and Cortexyme, Inc.
Lease Agreements
Cortexyme, Inc.
Biotechnology
2019
Underwriting Agreement between Cortexyme, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Credit Suisse Securities (USA) LLC, Dated May [•], 2019
Underwriting Agreements
Cortexyme, Inc.
Biotechnology
NY
2019
Cortexyme, Inc. Common Stock Certificate Issued by American Stock Transfer & Trust Company, LLC
Stock Agreements
Cortexyme, Inc.
Biotechnology
2019
Amended and Restated Indemnification Agreement between Cortexyme, Inc. and Indemnitee
Indemnification Agreements
Cortexyme, Inc.
Biotechnology
DE
2019
Cortexyme, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
DE
2019
Cortexyme, Inc. 2019 Employee Stock Purchase Plan
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
2019
Amended and Restated Investors' Rights Agreement by and among Cortexyme, Inc. and Certain Investors and Key Holders (May 23, 2018)
Investor Rights Agreements
Cortexyme, Inc.
Biotechnology
CA
2019
Sub-Sublease Agreement between Verily Life Sciences LLC and Cortexyme, Inc. for 259 East Grand Avenue
Lease Agreements
Cortexyme, Inc.
Biotechnology
DE
2019
Cortexyme, Inc. 2014 Stock Plan
Stock Agreements
Cortexyme, Inc.
Biotechnology
CA
2019
Cortexyme, Inc. Executive Incentive Bonus Plan
Bonus & Incentive Agreements
Cortexyme, Inc.
Biotechnology
CA
2019